Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019 E Nichols, JD Steinmetz, SE Vollset, K Fukutaki, J Chalek, F Abd-Allah, ... The Lancet Public Health 7 (2), e105-e125, 2022 | 2520 | 2022 |
Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis … JD Steinmetz, RRA Bourne, PS Briant, SR Flaxman, HRB Taylor, ... The Lancet Global Health 9 (2), e144-e160, 2021 | 1568 | 2021 |
Hearing loss prevalence and years lived with disability, 1990–2019: findings from the Global Burden of Disease Study 2019 LM Haile, K Kamenov, PS Briant, AU Orji, JD Steinmetz, A Abdoli, ... The Lancet 397 (10278), 996-1009, 2021 | 709 | 2021 |
Five insights from the global burden of disease study 2019 CJL Murray, C Abbafati, KM Abbas, M Abbasi, M Abbasi-Kangevari, ... The Lancet 396 (10258), 1135-1159, 2020 | 686 | 2020 |
Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990–2019: a systematic analysis for the Global … R Lozano, N Fullman, JE Mumford, M Knight, CM Barthelemy, C Abbafati, ... The Lancet 396 (10258), 1250-1284, 2020 | 602 | 2020 |
Global, regional, and national burden of bone fractures in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019 AM Wu, C Bisignano, SL James, GG Abady, A Abedi, E Abu-Gharbieh, ... The Lancet Healthy Longevity 2 (9), e580-e592, 2021 | 582 | 2021 |
Global injury morbidity and mortality from 1990 to 2017: results from the Global Burden of Disease Study 2017 SL James, CD Castle, ZV Dingels, JT Fox, EB Hamilton, Z Liu, ... Injury Prevention 26 (Suppl 2), i96-i114, 2020 | 314 | 2020 |
The burden of mental disorders, substance use disorders and self-harm among young people in Europe, 1990–2019: Findings from the Global Burden of Disease Study 2019 G Castelpietra, AKS Knudsen, EE Agardh, B Armocida, M Beghi, KM Iburg, ... The Lancet Regional Health–Europe 16, 2022 | 184 | 2022 |
Therapeutic potential of epigallocatechin gallate nanodelivery systems A Granja, I Frias, AR Neves, M Pinheiro, S Reis BioMed Research International 2017 (1), 5813793, 2017 | 149 | 2017 |
Nanoparticles for targeted brain drug delivery: what do we know? RGR Pinheiro, AJ Coutinho, M Pinheiro, AR Neves International Journal of Molecular Sciences 22 (21), 11654, 2021 | 146 | 2021 |
Measuring routine childhood vaccination coverage in 204 countries and territories, 1980–2019: a systematic analysis for the Global Burden of Disease Study 2020, Release 1 NC Galles, PY Liu, RL Updike, N Fullman, J Nguyen, S Rolfe, AN Sbarra, ... The Lancet 398 (10299), 503-521, 2021 | 142 | 2021 |
Quercetin lipid nanoparticles functionalized with transferrin for Alzheimer's disease RGR Pinheiro, A Granja, JA Loureiro, MC Pereira, M Pinheiro, AR Neves, ... European Journal of Pharmaceutical Sciences 148, 105314, 2020 | 140 | 2020 |
Liposomes as drug delivery systems for the treatment of TB M Pinheiro, M Lucio, JLFC Lima, S Reis Nanomedicine 6 (8), 1413-1428, 2011 | 139 | 2011 |
Epigallocatechin gallate nanodelivery systems for cancer therapy A Granja, M Pinheiro, S Reis Nutrients 8 (5), 307, 2016 | 134 | 2016 |
Mucoadhesive chitosan-coated solid lipid nanoparticles for better management of tuberculosis ACC Vieira, LL Chaves, S Pinheiro, S Pinto, M Pinheiro, SC Lima, ... International journal of pharmaceutics 536 (1), 478-485, 2018 | 130 | 2018 |
The formulation of nanomedicines for treating tuberculosis A Costa, M Pinheiro, J Magalhães, R Ribeiro, V Seabra, S Reis, ... Advanced drug delivery reviews 102, 102-115, 2016 | 125 | 2016 |
Design of a nanostructured lipid carrier intended to improve the treatment of tuberculosis M Pinheiro, R Ribeiro, A Vieira, F Andrade, S Reis Drug design, development and therapy, 2467-2475, 2016 | 97 | 2016 |
Global, regional, and national sex-specific burden and control of the HIV epidemic, 1990–2019, for 204 countries and territories: the Global Burden of Diseases Study 2019 D Jahagirdar, MK Walters, A Novotney, ED Brewer, TD Frank, A Carter, ... The Lancet HIV 8 (10), e633-e651, 2021 | 92 | 2021 |
RVG29-functionalized lipid nanoparticles for quercetin brain delivery and Alzheimer’s disease RGR Pinheiro, A Granja, JA Loureiro, MC Pereira, M Pinheiro, AR Neves, ... Pharmaceutical Research 37, 1-12, 2020 | 85 | 2020 |
Mannosylated solid lipid nanoparticles for the selective delivery of rifampicin to macrophages ACC Vieira, LL Chaves, M Pinheiro, SAC Lima, D Ferreira, B Sarmento, ... Artificial cells, nanomedicine, and biotechnology 46 (sup1), 653-663, 2018 | 76 | 2018 |